CoVs | Coronaviruses |
CNS | Central nervous system |
SARS-CoV-2 MERS-CoV |
Severe acute respiratory syndrome coronavirus 2 Middle East respiratory syndrome coronavirus |
ARDS | Acute respiratory distress syndrome |
WHO | World Health Organization |
HIVs | Human immunodeficiency viruses |
SIV | Immunodeficiency virus |
GP41 | Glycoprotein-41 |
CCR5 | C-C chemokine receptor-5 |
CXCR4 | C-C chemokine receptor-4 |
(IFI)-16 | Interferon-gamma induced protein-16 |
IL-1β | Interleukin-1β |
ACE2 | Angiotensin-converting enzyme-2 |
FGF2 | Basic fibroblast growth factor 2 |
GCSF | Granulocyte-colony stimulating factor |
IFNγ | Interferon-gamma |
IP10 | IFN-γ-inducible protein-10 |
MCP1 | Monocyte chemoattractant protein 1 |
MIP1A | Macrophage inflammatory proteins |
TNF-α | Tumor necrosis factor-alpha |
TGF-β | Transforming growth factor-beta |
NCBD | National Center for Biotechnology Development |
FDA | Food and Drug Administration |
LPV | Lopinavir |
RTV | Ritonavir |
PWH | People with HIV |